Literature DB >> 18458719

Treating depression and anxiety in primary care.

.   

Abstract

Entities:  

Year:  2008        PMID： 18458719      PMCID： PMC2292431          DOI： 10.4088/pcc.v10n0209

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  44 in total

1.  Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

Authors:  M Fava; J F Rosenbaum; S L Hoog; R G Tepner; J B Kopp; M E Nilsson
Journal:  J Affect Disord       Date:  2000-08       Impact factor: 4.839

Review 2.  Management of anxiety disorders: the added challenge of comorbidity.

Authors:  D L Dunner
Journal:  Depress Anxiety       Date:  2001       Impact factor: 6.505

3.  Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.

Authors:  M Fava; R Judge; S L Hoog; M E Nilsson; S C Koke
Journal:  J Clin Psychiatry       Date:  2000-11       Impact factor: 4.384

4.  Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction.

Authors:  R C Ziegelstein; J A Fauerbach; S S Stevens; J Romanelli; D P Richter; D E Bush
Journal:  Arch Intern Med       Date:  2000-06-26

5.  Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents.

Authors:  H W Cohen; G Gibson; M H Alderman
Journal:  Am J Med       Date:  2000-01       Impact factor: 4.965

6.  Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.

Authors:  R M Hirschfeld; J B Williams; R L Spitzer; J R Calabrese; L Flynn; P E Keck; L Lewis; S L McElroy; R M Post; D J Rapport; J M Russell; G S Sachs; J Zajecka
Journal:  Am J Psychiatry       Date:  2000-11       Impact factor: 18.112

7.  Recurrence after recovery from major depressive disorder during 15 years of observational follow-up.

Authors:  T I Mueller; A C Leon; M B Keller; D A Solomon; J Endicott; W Coryell; M Warshaw; J D Maser
Journal:  Am J Psychiatry       Date:  1999-07       Impact factor: 18.112

8.  Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study.

Authors:  S L Larson; P L Owens; D Ford; W Eaton
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

9.  Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood.

Authors:  C Heim; D J Newport; S Heit; Y P Graham; M Wilcox; R Bonsall; A H Miller; C B Nemeroff
Journal:  JAMA       Date:  2000-08-02       Impact factor: 56.272

10.  Depression and long-term mortality risk in patients with coronary artery disease.

Authors:  J C Barefoot; M J Helms; D B Mark; J A Blumenthal; R M Califf; T L Haney; C M O'Connor; I C Siegler; R B Williams
Journal:  Am J Cardiol       Date:  1996-09-15       Impact factor: 2.778
View more
  3 in total

1.  Mindfulness Training Enhances Self-Regulation and Facilitates Health Behavior Change for Primary Care Patients: a Randomized Controlled Trial.

Authors:  Richa Gawande; My Ngoc To; Elizabeth Pine; Todd Griswold; Timothy B Creedon; Alexandra Brunel; Angela Lozada; Eric B Loucks; Zev Schuman-Olivier
Journal:  J Gen Intern Med       Date:  2018-12-03       Impact factor: 5.128

2.  Insurance-Reimbursable Mindfulness for Safety-Net Primary Care Patients: A Pilot Randomized Controlled Trial.

Authors:  Richa Gawande; Elizabeth Pine; Todd Griswold; Timothy Creedon; Zayda Vallejo; Elana Rosenbaum; Angela Lozada; Zev Schuman-Olivier
Journal:  Mindfulness (N Y)       Date:  2019-03-18

Review 3.  The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practice.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Hans-Peter Volz; Utako Birgit Barnikol; Erich Seifritz; Siegfried Kasper
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-03-22       Impact factor: 5.270
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.